Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2012
12/06/2012WO2012165714A1 Gene associated with non-biological stress resistance, and transformed plant
12/06/2012WO2012165621A1 TABLET CONTAINING LIMAPROST AND β-CYCLODEXTRIN
12/06/2012WO2012165616A1 OLIGONUCLEOTIDE DERIVATIVE, OLIGONUCLEOTIDE DERIVATIVE-CONTAINING PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PHARMACEUTICAL COMPOSITION FOR DIAGNOSIS, AND OLIGONUCLEOTIDE DERIVATIVE FOR REGULATION OF miRNA FUNCTION
12/06/2012WO2012165610A1 Composition for maintaining or improving skin barrier function
12/06/2012WO2012165547A1 Method for manufacturing pyrazole derivative
12/06/2012WO2012165406A1 Psychic energizer agent and psychic energizer composition
12/06/2012WO2012165399A1 Imidazopyridine compound
12/06/2012WO2012165398A1 Cycloalkyloxybiaryl compound
12/06/2012WO2012165394A1 Anti-tumor agent
12/06/2012WO2012165345A1 Composition for preventing and/or ameliorating cancer-related irreversible metabolism disorders
12/06/2012WO2012165314A1 Amide compound
12/06/2012WO2012165309A1 Composition for external use
12/06/2012WO2012165262A1 Benzylamine derivative
12/06/2012WO2012165254A1 Ropinirole-containing adhesive skin patch and packaged product thereof
12/06/2012WO2012165253A1 Ropinirole-containing adhesive patch and packaging therefor
12/06/2012WO2012164969A1 Pharmaceutical composition for preventing and/or treating cancer, containing substituted phenanthrene compound as active ingredient
12/06/2012WO2012164936A1 Suv39h2 as a target gene for cancer therapy and diagnosis
12/06/2012WO2012164927A1 Hair growth and hair restoration material
12/06/2012WO2012164582A1 Preparation of 3-[2-[4-((6-fluoro-1, 2-benzisoxazol-3-yl)-l-piperidinyl)-6, 7, 8, 9-tetrahydro-9-hydroxy-2-methyl-4h-pyrido[ 1, 2-a]-pyrimidin-4-one (paliperidone) and paliperidone palmitate.
12/06/2012WO2012164578A1 Compositions and methods for preparing immediate release formulations of nilotinib
12/06/2012WO2012164575A2 Amorphous ritonavir co-precipitated
12/06/2012WO2012164572A1 Substituted 4-arylthiazoles and process of preparation thereof
12/06/2012WO2012164535A1 Antioxidant composition for the reduction of the causes of reduced male reproductive capacity
12/06/2012WO2012164497A1 A synergistic pharmaceutical combination for the treatment of squamous cell carcinoma of head and neck
12/06/2012WO2012164494A1 Composition for controlled release of buprenorphine
12/06/2012WO2012164473A1 3-spirocyclic piperidine derivatives as ghrelin receptor agonists
12/06/2012WO2012164398A2 Modulation of the ubiquitin-proteasome system (ups)
12/06/2012WO2012164358A1 Compositions comprising antibacterial agent and tazobactam
12/06/2012WO2012164356A1 A method of managing hypercortisolemia, headache disorders, neuropathic pain and related disorders
12/06/2012WO2012164286A1 Novel ticagrelor co - crystal
12/06/2012WO2012164241A1 Pharmaceutical antiretroviral composition
12/06/2012WO2012164234A1 Novel treatments
12/06/2012WO2012164118A1 Bioactive polyphenolic compounds containing sulphur or selenium and uses thereof
12/06/2012WO2012164103A2 Blockers of the nogo-a s1pr pathway for the treatment of diseases characterized by neuronal damage and lack of subsequent repair
12/06/2012WO2012164096A1 Process for the production of estetrol intermediates
12/06/2012WO2012164095A1 Process for the production of estetrol intermediates
12/06/2012WO2012164085A1 Glycine b antagonists
12/06/2012WO2012164071A1 Imidazole derivatives
12/06/2012WO2012164060A1 Methods of treating mesothelioma with a pi3k inhibitor compound
12/06/2012WO2012164055A2 New compounds, synthesis and use thereof in the treatment of pain
12/06/2012WO2012164047A1 Sucrose octasulfates of calcium, preparation method thereof and pharmaceutical and cosmetic uses of same
12/06/2012WO2012163997A1 Sucrose octasulfates of magnesium, preparation method thereof and pharmaceutical and cosmetic uses of same
12/06/2012WO2012163990A1 Sglt-2 inhibitors for treating metabolic disorders in patients treated with neuroleptic agents
12/06/2012WO2012163948A1 Pesticidal mixtures including isoxazoline derivatives
12/06/2012WO2012163942A1 Substituted aminoimidazopyridazines
12/06/2012WO2012163938A1 Fe(iii) 2,4-dioxo-1-carbonyl complexes for treatment and prophylaxis of iron deficiency symptoms and iron deficiency anaemias
12/06/2012WO2012163937A2 Solid solutions of polyphenols
12/06/2012WO2012163936A1 Process for the synthesis of benzotriazoles useful as uv-filters
12/06/2012WO2012163934A1 Amino-substituted-alkyloxy-benzo[e]pyrido[4,3-b]indole derivatives as new potent kinase inhibitors
12/06/2012WO2012163933A1 Amino-substituted-alkyloxy-benzo[e]pyrido[4,3-b]indole derivatives as new potent kinase inhibitors
12/06/2012WO2012163928A2 Wash composition
12/06/2012WO2012163925A1 Substituted terpyridines
12/06/2012WO2012163893A1 Composition and tablet comprising raltegravir
12/06/2012WO2012163833A1 Rhamno-polysaccharide from enterococcus faecium clonal complex 17 and uses thereof
12/06/2012WO2012163827A2 Ophthalmic preparation comprising a pgf2alpha analogue
12/06/2012WO2012163814A1 Cancer treatment by combining dna molecules mimicking double strand breaks with hyperthermia
12/06/2012WO2012163792A1 Novel p2x7r antagonists and their use
12/06/2012WO2012163790A1 Spiro-[1,3]-oxazines and spiro-[1,4]-oxazepines as bace1 and/or bace2 inhibitors
12/06/2012WO2012163724A1 Triazolopyridine compounds
12/06/2012WO2012163665A1 Transdermal therapeutic system comprising buprenorphine and an alpha-hydroxy acid
12/06/2012WO2012163590A1 Anti-inflammatory composition
12/06/2012WO2012163589A1 Polyphenol composition for preventing or treating atherosclerosis
12/06/2012WO2012163563A1 New strontium salts, synthesis and use thereof in the treatment of osteoporosis
12/06/2012WO2012163546A1 Pharmaceutical composition comprising dapagliflozin and cyclodextrin
12/06/2012WO2012163501A1 Nasal pharmaceutical formulation
12/06/2012WO2012163456A1 Novel p2x7r antagonists and their use
12/06/2012WO2012163366A1 A composition comprising at least one alginate for use in treatment and/or prevention of overweight
12/06/2012WO2012163365A1 Combinations of serotonin receptor agonists for treatment of movement disorders
12/06/2012WO2012163291A1 Phenylpiperazine derivative for inhibiting tumor metastasis and tumor angiogenesis
12/06/2012WO2012163290A1 Pharmaceutical compositions
12/06/2012WO2012163267A1 Compound chemical medicine acting on respiratory disease, preparation process and use thereof
12/06/2012WO2012163264A1 Saucernetin structurally simplified substance and preparation method therefor and pharmaceutical composition and use thereof
12/06/2012WO2012163236A1 Pyridothiazepine derivative, preparation method and uses therefor
12/06/2012WO2012163179A1 Hexahydrodibenzo[a,g]quinolizine compound, preparation method therefor, pharmaceutical composition and use thereof
12/06/2012WO2012163174A1 Pharmaceutical use of 2-(4-morpholinoaniline)-6-cyclohexyl aminopurine and pharmaceutically acceptable salt or derivative thereof
12/06/2012WO2012163088A2 Medicine for treating kidney and heart disease and the uses thereof
12/06/2012WO2012162945A1 Mangiferin aglycone crystal form i and preparation method thereof
12/06/2012WO2012162912A1 Benzothiazinethione derivatives and their preparative methods and uses
12/06/2012WO2012162828A1 Matriptase inhibitors and uses thereof against orthomyxoviridae infections
12/06/2012WO2012162814A1 Novel antibacterial combination therapy
12/06/2012WO2012162812A1 Polymorphism panels predictive of anthracycline-induced cardiotoxicity (act)
12/06/2012WO2012162796A1 Methods and compositions for enhancing fertility and/or inhibiting pregnancy failure and restoring glucose tolerance
12/06/2012WO2012162789A1 Polymers for reversing heparin-based anticoagulation
12/06/2012WO2012162778A1 Oral pharmaceutical composition and use thereof
12/06/2012WO2012162777A1 Oral pharmaceutical composition comprising a proton pump inhibitor and a prokinetic agent that can be used in excess stomach acid disorders
12/06/2012WO2012162776A1 Pharmaceutical composition for treating benign prostatic hyperplasia
12/06/2012WO2012142498A3 Mif inhibitors and their uses
12/06/2012WO2012142067A3 Formulations, salts, and solid forms of substituted cyclohexylmethanamines, processes for preparation, and uses thereof
12/06/2012WO2012139043A3 Selective neuronal nitric oxide synthase inhibitors
12/06/2012WO2012138653A3 Treatment regimens
12/06/2012WO2012138184A3 Drug-eluting stent comprising chitosan coating layer, and preparation method thereof
12/06/2012WO2012135856A3 Very low dose vinorelbine for treatment of cancer
12/06/2012WO2012134187A3 Pharmaceutical composition for preventing or treating macular degeneration
12/06/2012WO2012129452A8 Propynoic acid carbamoyl methyl-amides and pharmaceutical compositions and methods based thereon
12/06/2012WO2012127506A4 Substituted fused tricyclic compounds, compositions and medicinal applications thereof
12/06/2012WO2012125447A3 Piperazinedione compounds
12/06/2012WO2012121919A3 Selective ligands for the dopamine 3 (d3) receptor and methods of using the same
12/06/2012WO2012119049A3 Nutritional compositions comprising prune extract and bioavailable curcumin
12/06/2012WO2012106287A8 Methods of treating acute kidney injury with retinoic acid
12/06/2012WO2012103028A3 Methods and compositions for preparing noribogaine from voacangine
1 ... 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 943 944 945 ... 7860